-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AB-248 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AB-248 in Solid Tumor Drug Details: AB-248 is under development for the treatment of locally...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – MZE-001 in Pompe Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MZE-001 in Pompe Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.MZE-001 in Pompe Disease Drug Details:MZE-001 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aminolevulinic Acid Hydrochloride in Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aminolevulinic Acid Hydrochloride in Anemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Aminolevulinic Acid Hydrochloride in Anemia Drug Details:Aminolevulinic acid hydrochloride (5-ALA) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aminolevulinic Acid Hydrochloride in Mild Cognitive Impairment
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aminolevulinic Acid Hydrochloride in Mild Cognitive Impairment report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Aminolevulinic Acid Hydrochloride in Mild Cognitive ImpairmentDrug Details:Aminolevulinic acid hydrochloride...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AZD-7789 in Non-Small Cell Lung Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AZD-7789 in Non-Small Cell Lung Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AZD-7789 in Non-Small Cell Lung Carcinoma Drug Details: AZD-7789 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – YT-1920 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - YT-1920 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR)...
-
Product Insights
Contrast Agents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Contrast Agents Pipeline Market Report Overview The Contrast Agents pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Positron Emitting Tomography Contrast Agents ·       Magnetic Resonance Imaging (MRI) Contrast Agents ·       Gadolinium-based MRI Contrast Agents...